Molecular mechanisms of trigeminal neuralgia: A systematic review.


Journal

Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039

Informations de publication

Date de publication:
01 2021
Historique:
received: 17 11 2020
revised: 26 11 2020
accepted: 27 11 2020
pubmed: 19 12 2020
medline: 22 6 2021
entrez: 18 12 2020
Statut: ppublish

Résumé

To conduct a systematic review of the available literature for primary research articles identifying potential gene mutations, polymorphisms and other molecular regulatory mechanisms related to trigeminal neuralgia in order to identify the genetic and molecular models of primary trigeminal neuralgia currently being investigated. PubMed and Web of Science were systematically searched to identify primary research articles discussing genetic predictors of trigeminal neuralgia and neuropathic pain that were published prior to July 2020. This review was conducted according to PRISMA guidelines. Out of the 333 articles originally identified, a total of 14 papers were selected for study inclusion. These articles included 5 human studies, 6 mouse studies and 3 rat studies. Four articles investigated sodium channels, 1 investigated a sodium channel and nerve growth factor receptor, 2 investigated potassium channels, 1 investigated calcium channels, 1 investigated the downstream regulatory element antagonist modulator protein, 1 investigated the dynorphin-kappa opioid receptor system, 1 investigated TRPA1, 1 investigated the Nrg1/ErbB3/ErbB2 signaling complex, 1 investigated a serotonin transporter and 1 investigated potassium channels, sodium channels, calcium channels, chloride channels, TRP channels and gap junctions. Researchers have identified multiple genetic and molecular targets involved with potential pathophysiologies that have a relationship to the creation of trigeminal neuralgia. At this time, there does not seem to be clear causal frontrunner, demonstrating the possibility that genetic predisposition to trigeminal neuralgia may involve multiple genes and/or downstream products, such as ion channels.

Identifiants

pubmed: 33338828
pii: S0303-8467(20)30740-X
doi: 10.1016/j.clineuro.2020.106397
pii:
doi:

Substances chimiques

Ion Channels 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106397

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Cynthia A Smith (CA)

Rutgers New Jersey Medical School, Department of Neurological Surgery, Newark, NJ, USA. Electronic address: cs1229@njms.rutgers.edu.

Boris Paskhover (B)

Rutgers New Jersey Medical School, Department of Otolaryngology - Head & Neck Surgery, Newark, NJ, USA. Electronic address: borpas@njms.rutgers.edu.

Antonios Mammis (A)

NYU Grossman School of Medicine, Department of Neurosurgery, New York, NY, USA. Electronic address: antonios.mammis@nyulangone.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH